NEWS
Federal Circuit: USPTO Incorrectly Calculates Patent Term Adjustment (PTA)
Any “Delay Caused by Applicant” Found by USPTO to Reduce PTA Should be Re-Evaluated in View of...
Chris Griffith Speaks at 9th Asia Pharma R&D Leaders Conference
Chris Griffith was invited to speak at the 9th Asia Pharma R&D Leaders Conference in Beijing...
US Supreme Court Decides that a “Secret” Sale or Offer for Sale of a Claimed Invention is Invalidating Prior Art Under the AIA
AIA did not change law pertaining to “on sale” activities. The US Supreme Court in Helsinn...
Super Lawyers Recognizes Green Griffith 2019 Award-Winning Attorneys
Green Griffith is pleased to announce that 8 of our attorneys have been named 2019 Illinois Super...
Hatch-Waxman Integrity Act Introduced in US House and Senate
The Bill (H.R. 7251) would require companies desiring to launch a generic or biosimilar product to...
Caryn Borg-Breen to Speak at Chicago Women in Law Conference
Green Griffith Partner, Caryn Borg-Breen, will be a featured speaker at the Morning Lineup Live...
Chris Griffith Speaks at 3rd Annual China Pharma IP Summit
Chris Griffith and Jeff Ward were invited to attend the 3rd China Pharma IP Summit in Beijing held...
USPTO Changes Claim Construction Standard for Patent Trial and Appeal Board (PTAB) Proceedings
The United States Patent and Trademark Office (USPTO) has discarded the “broadest...
District Court Finds Safe Harbor Defense Does Not Apply to Continued Process Verification Program Undertaken by Biosimilar Applicant
A Delaware District Court has determined that drug substance batches manufactured pursuant to a...